Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ricard D et al. – The abovementioned issue is of clinical importance given the number of patients treated for brain tumors, including patients with brain metastases, and the number of patients who are at high risk for brain metastasis who could benefit from prophylactic cranial irradiation. Moreover, drugs used in nonbrain tumors are now recognized to impair brain normal functioning.

Related Articles

To Tell or Not to Tell: The Community Wants to Know About Expensive Anticancer Drugs As a Potential Treatment Option
Journal of Clinical Oncology, 10/06/09    Relevance Score: 66%

Promising Novel Treatment For Human Cancer Chrysanthemum Indicum Extract
ScienceDaily, 10/19/09    Relevance Score: 65%

A practical approach to using methotrexate
Dermatology in Practice, 10/14/09    Relevance Score: 65%

Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09    Relevance Score: 65%

Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo
Cancer Science, 10/26/09    Relevance Score: 64%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address